Target intelligence / Profile preview

Umbilical cord blood-derived mesenchymal stem cell paracrine and contact-dependent interactome (UCB-MSC interactome) (UCB-MSC interactome)

Target
UCB-MSC interactome
Molecular classification
Other, Cellular interactome, Secretome
01

Overview

The Umbilical cord blood-derived mesenchymal stem cell (UCB-MSC) paracrine and contact-dependent interactome refers to the complex network of secreted factors and membrane-bound proteins through which these cells communicate with their environment (Frontiers in Immunology, 2019). The paracrine component, often called the secretome, includes cytokines like IL-10 and TGF-β, growth factors such as VEGF and HGF, and extracellular vesicles that modulate immune responses and promote tissue regeneration (PMID: 29633143). The contact-dependent component involves direct cell-to-cell interactions via molecules like ICAM-1, VCAM-1, and PD-L1, which are crucial for MSC homing and T-cell suppression (PMID: 25979354). This interactome plays a vital role in treating conditions like graft-versus-host disease (GVHD) and inflammatory disorders by creating a pro-regenerative and immunosuppressive milieu (PMID: 32501141). Because it encompasses hundreds of proteins and signaling pathways rather than a single molecular entity, it is characterized as a complex biological system rather than a traditional drug target (Nature Communications, 2019). Understanding the specific components of this interactome is critical for developing cell-free secretome therapies that aim to replicate the benefits of MSCs without the risks of live cell transplantation (PMID: 30712445).

Other names
UCB-MSC secretomeUCB-MSC contactomeUmbilical cord blood mesenchymal stem cell signaling networkUCB-MSC paracrine factors
02

Mechanism of action

Modulation of the host immune system and tissue microenvironment through the release of soluble paracrine factors and direct cell-to-cell contact signaling (PMID: 31143231).

03

Biological functions

Immune responseCell proliferationAngiogenesisTissue repairAnti-inflammatory response
04

Disease associations

InflammationAutoimmune diseaseGraft-versus-host diseaseCardiovascular diseaseNeurological disorders
05

Safety considerations

Potential for tumorigenicityRisk of unwanted differentiationImmunogenicity in allogeneic applicationsLack of standardization in secretome production
06

Biomarkers

CD73CD90CD105Indoleamine 2,3-dioxygenase (IDO)Interleukin-10 (IL-10)Transforming growth factor beta (TGF-beta)

Beyond the preview

Go deeper on Umbilical cord blood-derived mesenchymal stem cell paracrine and contact-dependent interactome (UCB-MSC interactome) (UCB-MSC interactome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umbilical cord blood-derived mesenchymal stem cell paracrine and contact-dependent interactome (UCB-MSC interactome) (UCB-MSC interactome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call